Farhatullah Syed

Farhatullah Syed, also known as Sameer, currently serves as Group Leader/Senior Scientist at King Faisal Specialist Hospital and Research Centre, focusing on CAR T, CD34 product development, and clinical-grade vector production since September 2021. Previously, Farhatullah held the position of Senior Research Scientist and Clinical Trial Lead Scientist at ICH Events - UCL GOS Institute of Child Health from September 2016 to March 2022, where contributions included the CARAML project and CAR T cell immunotherapy trials. Farhatullah's extensive research background also includes roles as a Research Fellow at UCL GOS Institute of Child Health, a Research Associate at the University of Manchester and the University of Warwick, and a Bioinformatics Scientist at GETRIB in India. Educational credentials include a PhD in Molecular Virology from the University of Warwick, a Master of Science in Microbiology and Biotechnology from Periyar University, and recent qualifications in Higher Education teaching. Farhatullah is a Fellow of the Higher Education Academy.